☆ 4.5 Review

Biomarkers of endothelial dysfunction are associated with poor outcome in COVID-19 patients: A systematic review and meta-analysis

REVIEWS IN MEDICAL VIROLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients

Rita Indirli et al.

Summary: This study assessed the predictive value of copeptin and MR-proADM for in-hospital outcomes in COVID-19 patients. The results showed that both copeptin and MR-proADM could predict mortality, complications, and length of stay. They may be useful for early risk stratification and care intensification in COVID-19 patients.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Pathogenesis of COVID-19 described through the lens of an undersulfated and degraded epithelial and endothelial glycocalyx

Heidi N. du Preez et al.

Summary: The glycocalyx, a mesh of proteins and carbohydrates, plays an important role in protecting cells. The degree of sulfation and the position of sulfate groups on the glycocalyx determine its function. Highly sulfated glycocalyx can repel SARS-CoV-2, but undersulfation may facilitate viral entry. Sulfation also affects immune modulation, inflammation, vascular function, and protection against stress. Sulfation depends on the availability of inorganic sulfate, which can be influenced by genetic and environmental factors.

FASEB JOURNAL (2022)

Add to Collection

Article Acoustics

Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcome in pregnant women with COVID-19

J. Torres-Torres et al.

Summary: In addition to the lungs, the placenta and endothelium can be affected by SARS-CoV-2. High sFlt-1 levels are associated with severe COVID-19 in pregnant women and can predict severe adverse pregnancy events such as pneumonia, ICU admission, viral sepsis, and maternal death.

ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2022)

Add to Collection

Article Hematology

SARS-CoV-2 infection induces soluble platelet activation markers and PAI-1 in the early moderate stage of COVID-19

Abaher O. Al-Tamimi et al.

Summary: This study assessed the levels of coagulation and platelet activation markers in COVID-19 patients and found that soluble P-selectin, sCD40L, fibrinogen, and PAI-1 were induced at the moderate stage, suggesting platelet and coagulation system activation before patients required intensive care.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)

Add to Collection

Article Virology

Plasma Total Antioxidant Capacity and Carbonylated Proteins Are Increased in Pregnant Women with Severe COVID-19

Juan Mario Solis-Paredes et al.

Summary: The study found that pregnant women with severe COVID-19 have higher levels of oxidative damage and total antioxidant capacity, with a negative correlation between TAC and ANG-II as well as MDA levels, and a positive correlation with the sFlt-1/PlGF ratio.

VIRUSES-BASEL (2022)

Add to Collection

Article Medicine, General & Internal

Relationship Between Endothelial and Angiogenesis Biomarkers Envisage Mortality in a Prospective Cohort of COVID-19 Patients Requiring Respiratory Support

Felipe Maldonado et al.

Summary: This study aimed to evaluate whether early detection of endothelial and angiogenic biomarkers predicts mortality and major cardiovascular events in COVID-19 patients. The results showed that certain biomarkers had significantly increased concentrations in COVID-19 patients and could predict mortality. Furthermore, serum samples from COVID-19 patients enhanced the migration ability of endothelial cells.

FRONTIERS IN MEDICINE (2022)

Add to Collection

Article Immunology

Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study

Abdisa Tufa et al.

Summary: This study aimed to evaluate plasma inflammatory mediator concentrations in patients with SARS-CoV-2 in Addis Ababa, Ethiopia and identify potential biomarkers related to disease severity. The results showed that CRP, SAA, VCAM-1, CXCL10, CCL22, and IL-10 levels may serve as reliable indicators of COVID-19 severity and aid in prognosis and treatment.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Plasma Endothelial and Oxidative Stress Biomarkers Associated with Late Mortality in Hospitalized COVID-19 Patients

Arturo Orea-Tejada et al.

Summary: Endothelial dysfunction and oxidative stress are independent indicators of a worse prognosis in hospitalized COVID-19 patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Von Willebrand Factor and ADAMTS-13 Are Associated with the Severity of COVID-19 Disease

Nataliya Dolgushina et al.

Summary: Coagulopathy in COVID-19 patients is caused by systemic hypercoagulation and inflammation. Endothelial dysfunction leads to the release of tissue factor and von Willebrand factor, resulting in prothrombinase activation. The vWF/ADAMTS-13 ratio can be used to assess the severity of the disease.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

Article Immunology

Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects

Geir Hetland et al.

Summary: This study investigates prognostic factors for the severity of complications associated with ChAdOx1 vaccination. The levels of H3-NETs and calprotectin were significantly increased in VITT patients and correlated with the severity of vaccination side effects. These inflammatory markers may be used as confirmatory tests in diagnosing VITT.

VACCINES (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Fibrinolytic Proteins and Factor XIII as Predictors of Thrombotic and Hemorrhagic Complications in Hospitalized COVID-19 Patients

Marina Marchetti et al.

Summary: This study provides a comprehensive characterization of hemostatic alterations in hospitalized COVID-19 patients, highlighting the correlation with inflammatory status. Fibrinolytic proteins and NLR may serve as predictors of thrombotic and hemorrhagic complications, respectively.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circulating Syndecan-1 as a Predictor of Persistent Thrombocytopenia and Lethal Outcome: A Population Study of Patients With Suspected Sepsis Requiring Intensive Care

Kosaku Hatanaka et al.

Summary: This study demonstrates that in septic patients, serum syndecan-1 levels are associated with 28-day mortality, coagulation failure, and renal failure. Elevated syndecan-1 levels may lead to persistent thrombocytopenia and a lethal outcome.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Add to Collection

Article Hematology

Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays

Danielle White et al.

Summary: This study aimed to explore thrombin generation in COVID-19 patients using a novel analyzer. Critical patients showed increased levels of fibrinogen, CRP, interleukin-6, and D-dimer compared to noncritical patients. Although critical patients had right-shifted thrombin generation, there were no significant differences in key thrombin generation parameters. Increased levels of tPA, TFPI, and VEGF in critical patients may indicate endothelial dysfunction or heparin-induced effects.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)

Add to Collection

Letter Hematology

Plasma P-selectin is an early marker of thromboembolism in COVID-19

Bank G. Fenyves et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Add to Collection

Article Immunology

Complement activation and endothelial perturbation parallel COVID-19 severity and activity

Massimo Cugno et al.

Summary: The study found that complement activation is enhanced during the progression of COVID-19 and dampened during remission, indicating its role in the pathophysiology of the disease. The association between complement activation and the biomarkers of endothelial damage suggests that complement may contribute to tissue injury and could be the target of specific therapy.

JOURNAL OF AUTOIMMUNITY (2021)

Add to Collection

Article Hematology

The ADAMTS13-von Willebrand factor axis in COVID-19 patients

Ilaria Mancini et al.

Summary: Severe COVID-19 patients exhibit an increased risk of thromboembolic events, with evidence of microthrombosis in the lungs of deceased patients. The study found a significant alteration of the VWF-ADAMTS13 axis in COVID-19 patients, with an elevated VWF:Ag to ADAMTS13 activity ratio strongly associated with disease severity, enhancing the hypercoagulable state and risk of microthrombosis in these patients.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Cell Biology

Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure

Gianluca Campo et al.

Summary: This study investigated the relationship between platelet activation, myocardial injury, and mortality in COVID-19 patients, and found that heightened platelet activation is associated with disease severity, myocardial injury, and mortality.

PLATELETS (2021)

Add to Collection

Article Infectious Diseases

Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients

Luis Garcia de Guadiana-Romualdo et al.

Summary: MR-proADM plays a role in the mid-term prognosis of COVID-19 patients and may assist physicians with risk stratification. The study found that MR-proADM levels were an independent predictor of 90-day mortality in COVID-19 patients.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Cell Biology

ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients

Alice G. Vassiliou et al.

Summary: Endothelial damage markers were found to be significantly elevated in ICU non-survivors compared to survivors upon admission, suggesting their potential use in predicting mortality in COVID-19. The prognostic values of specific endothelial biomarkers were greater than 0.85 according to ROC analysis.

CELLS (2021)

Add to Collection

Article Medicine, Research & Experimental

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Michael S. Abers et al.

Summary: Immune and inflammatory responses are important factors contributing to disease severity in COVID-19. This study identified specific immune-based biomarkers associated with mortality in COVID-19 patients, with some biomarkers consistently higher in those who died compared to those who recovered, suggesting their potential for early prediction of disease outcome.

JCI INSIGHT (2021)

Add to Collection

Article Medicine, General & Internal

MR-proADM as marker of endotheliitis predicts COVID-19 severity

Luis Garcia de Guadiana-Romualdo et al.

Summary: This study investigated the relationship between circulating mid-regional proadrenomedullin (MR-proADM) levels and the prognosis of COVID-19 patients, and found that MR-proADM was the best predictor for death and disease progression in these patients.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Letter Hematology

Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients

Mario Rodriguez Rodriguez et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2021)

Add to Collection

Letter Immunology

Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department

Wolfgang Bauer et al.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study

Giorgia Montrucchio et al.

Summary: In COVID-19 ICU patients, MR-proADM consistently showed higher values in non-survivors and better predicted mortality compared to other biomarkers. Repeated measurements of MR-proADM may aid in rapid and effective decision-making, while further studies are needed to elucidate the mechanisms behind the increase in MR-proADM in COVID-19 patients.

PLOS ONE (2021)

Add to Collection

Letter Hematology

ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19

Tiffany Pascreau et al.

THROMBOSIS RESEARCH (2021)

Add to Collection

Article Virology

Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19

Salvador Espino-Y-Sosa et al.

Summary: The sFlt-1/ANG-II ratio is associated with an increased probability of severe pneumonia, ICU admission, intubation, sepsis, and death in pregnant women with COVID-19.

VIRUSES-BASEL (2021)

Add to Collection

Article Virology

Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study

Crhistian-Mario Oblitas et al.

Summary: In critically ill COVID-19 patients, elevated MR-proADM levels on admission were associated with a higher risk of 30-day mortality and poor outcomes. MetHb and COHb levels were not found to be associated with prognosis in this study.

VIRUSES-BASEL (2021)

Add to Collection

Article Immunology

Glycocalyx as Possible Limiting Factor in COVID-19

Patricia P. Wadowski et al.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Hematology

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19

Erica Villa et al.

Summary: This study found that angiopoietin-2 could serve as an important predictor for in-hospital mortality and nonresolving pulmonary condition in COVID-19 patients. Dynamic assessment of angiopoietin-2 levels may provide early disease prediction information.

BLOOD ADVANCES (2021)

Add to Collection

Article Hematology

Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality

David M. Smadja et al.

Summary: The study reveals a significant correlation between the angiogenic factor PlGF and in-hospital mortality in COVID-19 patients, with PlGF levels above 30 pg/ml being identified as the best predictor. This suggests that PlGF blocking strategies could be a promising therapeutic approach for COVID-19.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Health Care Sciences & Services

Biomarkers Associated with Failure of Liberation from Oxygen Therapy in Severe COVID-19: A Pilot Study

Oh Joo Kweon et al.

Summary: This study compared patients with COVID-19 who were successfully weaned off oxygen therapy with those who failed to wean off, finding that qSOFA scores, SpO(2)/FiO(2), PCT, D-dimer, Ang-2, Ang-2/Ang-1, endocan levels, and TNF-alpha levels were significantly higher in the weaning failure group. Among these, 7-day endocan levels were the best predictor of weaning failure.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Add to Collection

Article Immunology

A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19)

Sajad Karampoor et al.

Summary: The study investigated the dynamic changes in Syndecan-1 levels in COVID-19 patients. Results showed that COVID-19 patients had significantly higher levels of SDC-1, CRP, IL-6, IL-10, and IL-18 compared to healthy subjects, with lower levels of Vitamin D. ICU patients exhibited higher levels of these markers compared to non-ICU patients. Tracking the markers indicated an initial increase followed by a decrease by day 10, suggesting that SDC-1, IL-6, and IL-18 could be valuable indicators in evaluating COVID-19 activity.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Add to Collection

Article Critical Care Medicine

Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study

Jos A. H. van Oers et al.

Summary: The study assessed the ability of MR-proADM and CT-proET-1 to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia. Both biomarkers showed good predictive ability for mortality at baseline and over time, with high accuracy in identifying non-survivors.

JOURNAL OF CRITICAL CARE (2021)

Add to Collection

Article Virology

The role of angiopoietin-2 and surfactant protein-D levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study

Handan Alay et al.

Summary: This study investigated the levels of serum surfactant-D (SP-D) and angiopoetin-2 (Ang-2) in predicting the severity of COVID-19 patients. The results showed that SP-D and Ang-2 levels were significantly higher in patients with more severe pneumonia, and they can serve as predictive factors in differentiating COVID-19 patients and determining disease severity.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Hematology

Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID-19 patients

Berangere S. Joly et al.

Summary: Clinical features, hemostatic laboratory parameters, VWF/ADAMTS13 axis, and ADAMTS13 conformation were investigated in critically ill COVID-19 patients at admission. The study found that an imbalance between high VWF antigen levels and normal or slightly decreased ADAMTS13 activity levels correlated with mortality, suggesting that these markers may reflect inflammation and endothelial damage rather than driving the thrombotic process of COVID-19.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Medicine, Research & Experimental

Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study

Emre Karsli et al.

Summary: This study demonstrates that sP-Selectin can serve as a valuable biomarker for diagnosing and predicting the need for intensive care treatment in COVID-19 infections.

LIFE SCIENCES (2021)

Add to Collection

Article Medicine, General & Internal

Role of Serum E-Selectin as a Biomarker of Infection Severity in Coronavirus Disease 2019

Alessandra Oliva et al.

Summary: This study compared sE-selectin levels in COVID-19 patients and found that higher levels were associated with increased risk of ICU admission, potentially serving as a predictor for disease severity.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Further Findings Concerning Endothelial Damage in COVID-19 Patients

Monica Gelzo et al.

Summary: Serum MCP-2 and P-selectin levels are associated with disease severity in COVID-19 patients. MCP-2 levels decrease and P-selectin levels increase in mild patients, while the opposite occurs in severe patients after 1 week of hospitalization. This suggests potential for targeted therapies based on these biomarkers.

BIOMOLECULES (2021)

Add to Collection

Article Medicine, General & Internal

Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection

Ivo M. B. Francischetti et al.

Summary: This study found that COVID-19 patients have thrombotic and microvascular complications, and the coagulation abnormalities have a multifactorial etiology. Biomarkers of endothelial cell, neutrophil activation, and fibrinolysis were elevated in severe disease group, correlating with severity. Postmortem specimens demonstrated potential links to immunothrombosis with upregulation of pulmonary TF and loss of thrombomodulin staining.

ECLINICALMEDICINE (2021)

Add to Collection

Article Hematology

Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis

Golzar Mobayen et al.

Summary: Severe COVID-19 in hemodialysis patients is associated with elevated VWF and decreased ADAMTS-13 levels. High soluble Syndecan-1 levels in severely ill patients are related to risk of death. Elevated VWF levels in severely ill patients are correlated with lower VWF sialic acid content, indicating altered VWF processing.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Medicine, General & Internal

Predictive Role of Haematological Determinants on Outcomes of Critically Ill COVID-19 Patients Admitted to Intensive Care Unit

Ahilanandan Dushianthan et al.

Summary: The study found that peak D-dimer and vWF-ADAMTS13-platelet axis are associated with ICU severity and outcome in severe COVID-19 patients admitted to ICU.

CUREUS JOURNAL OF MEDICAL SCIENCE (2021)

Add to Collection

Article Hematology

Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection

Sandra Lopez-Castaneda et al.

Summary: In hospitalized COVID-19 patients, alterations in inflammatory and coagulation biomarkers are closely related to poor prognosis, with significantly elevated levels of D-dimer and PAI-1 in severe cases, along with distinct differences in inflammatory markers between non-severe patients and those who succumbed to the disease.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2021)

Add to Collection

Article Hematology

Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality

Fien A. von Meijenfeldt et al.

Summary: The study found that COVID-19 patients with higher levels of respiratory support have significantly increased in vivo activation of coagulation and fibrinolysis, despite receiving anticoagulant therapy. Blood markers such as fibrinogen, von Willebrand factor, etc., also change with increasing levels of respiratory support.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)

Add to Collection

Article Hematology

Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis

Christophe Nougier et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Immunology

Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID-19

Christophe Guervilly et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19

Minako Yamaoka-Tojo

BIOMEDICAL JOURNAL (2020)

Add to Collection

Article Medicine, General & Internal

Covid-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome

Marco Ranucci et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Circulating markers of angiogenesis and endotheliopathy in COVID-19

Matthew L. Meizlish et al.

PULMONARY CIRCULATION (2020)

Add to Collection

Article Pharmacology & Pharmacy

Mending Leaky Blood Vessels: The Angiopoietin-Tie2 Pathway in Sepsis

Sascha David et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)

Add to Collection

Review Biotechnology & Applied Microbiology

Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?

Patrick Paulus et al.

BIOMARKERS (2011)

Add to Collection

Article Critical Care Medicine

Mechanical ventilation with high tidal volume induces inflammation in patients without lung disease

Roselaine Pinheiro de Oliveira et al.

CRITICAL CARE (2010)

Add to Collection

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

Add to Collection

Article Mathematical & Computational Biology

Quantifying heterogeneity in a meta-analysis

JPT Higgins et al.

STATISTICS IN MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.